Bicara Therapeutics Q3 EPS $(1.04) Misses $(0.81) Estimate
Benzinga Newsdesk 2 hours ago
NewsEarningsEarnings Misses
Bicara Therapeutics (NASDAQ:BCAX) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(0.81) by 28.4 percent. This is a 55.22 percent decrease over losses of $(0.67) per share
Bicara Therapeutics (NASDAQ:BCAX) reported quarterly losses of $(1.04) per share which missed the analyst consensus estimate of $(0.81) by 28.4 percent. This is a 55.22 percent decrease over losses of $(0.67) per share from the same period last year.